AEPGX
Price
$65.36
Change
+$0.75 (+1.16%)
Updated
Aug 21 closing price
Net Assets
137.41B
MRNPX
Price
$34.79
Change
+$0.21 (+0.61%)
Updated
Aug 21 closing price
Net Assets
625.11M
Interact to see
Advertisement

AEPGX vs MRNPX

AEPGX vs MRNPX Comparison Chart in %
View a ticker or compare two or three
VS
AEPGX vs. MRNPX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a StrongBuy and MRNPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 137B vs. MRNPX (625M). AEPGX pays higher dividends than MRNPX: AEPGX (2.56) vs MRNPX (0.00). AEPGX was incepted earlier than MRNPX: AEPGX (42 years) vs MRNPX (8 years). MRNPX (15.90) is less costly to investors than AEPGX (0.83). AEPGX is a more actively managed with annual turnover of: 50.00 vs. MRNPX (25.00). AEPGX has a lower initial minimum investment than MRNPX: AEPGX (250) vs MRNPX (5000000). AEPGX annual gain was more profitable for investors over the last year : 8.66 vs. MRNPX (6.72). AEPGX return over 5 years is better than : 1.00 vs. MRNPX (-15.83).
AEPGXMRNPXAEPGX / MRNPX
Total Expense Ratio0.830.9488%
Annual Report Gross Expense Ratio0.8315.905%
Fund Existence42 years8 years-
Gain YTD8.0157.443108%
Front Load6%N/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets137B625M21,920%
Annual Yield % from dividends2.560.00-
Returns for 1 year8.666.72129%
Returns for 3 years30.3054.4756%
Returns for 5 years1.00-15.83-6%
Returns for 10 years47.95N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDEYX22.040.15
+0.69%
Columbia Intrinsic Value Institutional 3
ADCIX24.720.16
+0.65%
American Century Disciplined Growth I
MFEHX180.291.02
+0.57%
MFS Growth R3
TRSLX6.590.03
+0.46%
Transamerica Small Cap Value R
DSEFX42.310.18
+0.43%
Domini Impact Equity Investor